Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:QTZM)

1.400 +0.010 (+0.72%)
Streaming Delayed Price Updated: 11:38 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about QTZM

Quantumzyme Announces Publication of Patents Supporting Sustainable Pharmaceutical Growth & Innovation
Via TheNewswire.com
Topics Intellectual Property
Quantumzyme Announces Publication of Patents Supporting Sustainable Pharmaceutical Growth & Innovation
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Corp. Participated in Enzyme Engineering XXVIII Conference in Denmark
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Quantumzyme Corp. Participated in Enzyme Engineering XXVIII Conference in Denmark
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Quantumzyme Corp. Announces USPTO Publication of Breakthrough Ibuprofen Patent
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Corp. Announces USPTO Publication of Breakthrough Ibuprofen Patent
Via TheNewswire.com
Topics Intellectual Property
Quantumzyme Announces Removal of OTC Markets Caveat Emptor Designation
Via TheNewswire.com
Quantumzyme Announces Removal of OTC Markets Caveat Emptor Designation
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme Responds to OTC Markets Caveat Emptor Designation and Denounces Unauthorized Promotion Activity
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme Responds to OTC Markets Caveat Emptor Designation and Denounces Unauthorized Promotion Activity
SAN DIEGO, CA - April 30, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, today announced that it is in contact with OTC... 
Via TheNewswire.com
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
SAN DIEGO, CA - April 28, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the key benefits and... 
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
SAN DIEGO, CA - April 23, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the upcoming publication of... 
Via TheNewswire.com
Topics Intellectual Property
Quantumzyme Highlights Enzyme Engineering Platform and Ongoing Work in Sustainable Ibuprofen Synthesis
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme: Advancing Enzymatic Innovation for a Sustainable Industrial Future
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme Introduces Manu Bharath Khareedhi as Independent Director, Looks to Strengthen Strategic Growth and Innovation
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme Introduces Manu Bharath Khareedhi as Independent Director, Looks to Strengthen Strategic Growth and Innovation
SAN DIEGO, CA - April 8, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, is pleased to introduce Manu Bharath... 
Via TheNewswire.com
Quantumzyme Signs MOU With Zummit Africa to Establish a Centre of Excellence in AI for Green Chemistry
SAN DIEGO, CA - April 4, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, has signed a Memorandum of... 
Via TheNewswire.com
Topics Artificial Intelligence
Quantumzyme Signs MOU With Zummit Africa to Establish a Centre of Excellence in AI for Green Chemistry
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme to Become Fully Reporting SEC Issuer, Unlocking New Growth Potential
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Quantumzyme to Become Fully Reporting SEC Issuer, Unlocking New Growth Potential
SAN DIEGO, CA - April 3, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, announced today that it will become a... 
Via TheNewswire.com
Topics Regulatory Compliance
Quantumzyme Highlights Breakthroughs in Enzymatic Catalysis at CCE 2025
SAN DIEGO, CA - April 1, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, is pleased to reflect on its successful... 
Via TheNewswire.com
Topics Emissions
Quantumzyme Highlights Breakthroughs in Enzymatic Catalysis at CCE 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Emissions
Quantumzyme Announces Vision to Lead the Future of Sustainable Industrial Biocatalysis
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme Announces Vision to Lead the Future of Sustainable Industrial Biocatalysis
SAN DIEGO, CA - March 27, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, is proud to introduce its mission and... 
Via TheNewswire.com
Topics Artificial Intelligence
Quantumzyme Unveils Enhanced Website to Drive Innovation and User Engagement
SAN DIEGO, CA - March 25, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, is excited to announce the launch of... 
Via TheNewswire.com
Quantumzyme Unveils Enhanced Website to Drive Innovation and User Engagement
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.